Comparison Chart Myriad Genetics, Inc.

Stocks

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 22:43:30 28/10/2026 HKT			5-day change	1st Jan Change
6.530 ^USD	+3.82%		+16.25%	+5.28%

10-22	Myriad Genetics Says New Results Show Potential of MRD Detection in Colorectal, Pancreatic Cancers	MT
10-22	Myriad Genetics, Inc. Releases New MONSTAR-SCREEN-3 Data Demonstrating The Potential Of Ultra-Sensitive MRD Detection In Colorectal And Pancreatic Cancers	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	MYRIAD GENETICS, INC.	Diagnostic & Testing Substances	+2.94%	+16.25%	+5.28%	-20.36%	-79.76%	602M